Notably, serum G6PD activity has been reported to increase with tumor stage and decrease after treatment in Merkel cell carcinoma, a type of skin cancer, which supports the broader clinical relevance of G6PD as a biomarker in oncology [18]. The gene discussed is G6PD; the disease is neoplasm.